VEGFA and Hepatic fibrosis: Although brivanib has previously been demonstrated to decrease tumorigenesis in several cancers including HCC through the regulation of VEGF and FGF signaling pathways, the effects of brivanib on liver fibrosis had not been studied [14], [17], [28].